Working… Menu
Trial record 1 of 96 for:    Celiac Disease | United States
Previous Study | Return to List | Next Study

Latiglutenase as a Treatment for Celiac Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03585478
Recruitment Status : Completed
First Posted : July 13, 2018
Last Update Posted : January 29, 2021
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Immunogenics, LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 22, 2020
Actual Study Completion Date : January 22, 2021